Insulin aspart, recombinant Subcutaneous and Pyrophosphate Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pyrophosphate Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pyrophosphate
Brand name: Technescan PYP
Synonyms: Technetium Tc 99m Pyrophosphate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pyrophosphate Injection-Insulin degludec
- Pyrophosphate Injection-Insulin Degludec (U-100) Prefilled Pens
- Pyrophosphate Injection-Insulin Degludec (U-100) Vials
- Pyrophosphate Injection-Insulin Degludec (U-200) Prefilled Pens
- Pyrophosphate Injection-Insulin degludec and liraglutide
- Pyrophosphate Injection-Insulin degludec and liraglutide Subcutaneous